Kintegral Advisory LLC trimmed its position in shares of The Allstate Co. (NYSE:ALL – Free Report) by 4.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,928 shares of the insurance provider’s stock after selling 276 shares during the period. Kintegral Advisory LLC’s holdings in Allstate were worth $1,149,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Strategic Financial Concepts LLC lifted its position in shares of Allstate by 15,062.3% during the fourth quarter. Strategic Financial Concepts LLC now owns 1,119,129 shares of the insurance provider’s stock worth $215,757,000 after purchasing an additional 1,111,748 shares during the last quarter. Pathway Financial Advisers LLC raised its stake in Allstate by 18,472.5% during the third quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock valued at $199,642,000 after buying an additional 1,047,019 shares in the last quarter. TimesSquare Capital Management LLC bought a new position in Allstate during the 3rd quarter worth approximately $77,819,000. Los Angeles Capital Management LLC grew its position in shares of Allstate by 688.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider’s stock worth $87,292,000 after acquiring an additional 401,901 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec increased its holdings in shares of Allstate by 291.9% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 356,065 shares of the insurance provider’s stock valued at $67,528,000 after acquiring an additional 265,213 shares during the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Allstate Price Performance
Shares of ALL opened at $185.51 on Friday. The Allstate Co. has a one year low of $153.87 and a one year high of $209.88. The stock’s fifty day moving average is $190.25 and its 200-day moving average is $190.29. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36. The firm has a market capitalization of $49.12 billion, a price-to-earnings ratio of 10.92, a price-to-earnings-growth ratio of 1.03 and a beta of 0.52.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the stock. Keefe, Bruyette & Woods increased their target price on shares of Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a report on Tuesday, February 11th. Piper Sandler increased their price objective on shares of Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 26th. Morgan Stanley lifted their target price on Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a research note on Thursday, November 7th. Evercore ISI upgraded Allstate from an “in-line” rating to an “outperform” rating in a research report on Wednesday, January 8th. Finally, UBS Group boosted their price objective on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Allstate currently has an average rating of “Moderate Buy” and an average target price of $217.94.
Insider Activity at Allstate
In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.80% of the company’s stock.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- Election Stocks: How Elections Affect the Stock Market
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- DuPont’s Electronics Spinoff: The Start of Something Big
- Top Biotech Stocks: Exploring Innovation Opportunities
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.